Join us for a poster highlight of the top abstracts from the Alcohol-associated Liver Disease (ALD) SIG. 

The following poster categories will be in the Poster Hall:
<ul>
<li>Hepatobiliary Neoplasia</li>
<li>Health Services and Public Health Research</li>
<li>Liver Transplantation and Liver Surgery</li>
<li>Liver Fibrogenesis and Non-Parenchymal Cell Biology</li>
<li>Metabolic and Genetic Disease</li>
</ul>

The following poster categories will be in the Poster Hall:
<ul>
<li>Diagnostics and Biomarkers - MASLD and MASH</li>
<li>Health Disparities/Health Equity Research</li>
<li>MASLD/MASH -Epidemiology and Natural History, Prevention and Outcomes</li>
<li>Hepatitis - Other Infections</li>
<li>Advanced Practice Providers (NP, PA, RN, PharmD, etc.)</li>
<li>Portal Hypertension and Other Complications of Cirrhosis</li>
<li>MASLD/MASH -Treatment: Non-pharmacologic</li>
</ul>

This interactive symposium will feature expert perspectives on advancing the standard of care for individuals living with PBC.&nbsp;Discussion will focus on strategies aimed at achieving normalization of biochemical markers, alleviating symptom burden, and exploring the potential role of new and emerging therapies in improving patient outcomes.<br />
<br />
Supported by: Gilead Sciences, Inc.<br />
Organized by:&nbsp;Clinical Care Options, LLC<br />
<br />
For more information and to register, visit:&nbsp;<a href="https://clinicaloptions.com/events/pbc-care-innovations/pbc-care-innova… />
<br />
Important Note: Continuing education credits for Satellite Symposia are offered by the sponsoring organizations. These sessions are not accredited by AASLD.

Invitation only!

Join us for a poster highlight of the top abstracts from the Hepatitis C SIG.&nbsp;<br />
&nbsp;

<p>Come discuss the recent International Liver Transplantation Society guideline update on portopulmonary hypertension with one of the authors behind the guideline! Read the guideline here:&nbsp;<br />
<a href="https://journals.lww.com/lt/abstract/9900/international_liver_transplan…;

<p>3:45-3:55 PM- Presentation</p>

<p>3:55-4:15 PM- Audience Q&amp;A and Discussion</p>

<p>&nbsp;</p>

This workshop introduces the concept of point-of-care ultrasonography (POCUS) of the liver as an extension of the clinical exam to be performed by hepatology clinicians. Presenters provide a rationale for the use of POCUS, the basics of liver ultrasonography, common applications, and a path to implement POCUS in clinical practice. Participants will also receive hands-on training on performing point-of-care ultrasound examinations of the liver.<br />
<br />
<em>This session is supported by in-kind contributions (provision of ultrasound equipment) from GE Healthcare, Mindray, NEO Medical, and Siemens Healthineers.</em><br />
&nbsp;

The clinical significance of findings in liver biopsies exhibiting steatotic liver disease (MASLD, MetALD, MASH) are the focus of this session. Presentations and discussion examine some of the interpretive issues that pertain to the new steatotic liver disease category MetALD, ie, whether it is feasible to distinguish contribution or features of alcohol-related findings from MASLD only or MASH only. Metabolic diseases (eg,&nbsp;Wilson disease or alpha-1 antitrypsin deficiency) and DILI with a steatohepatitic pattern (eg, methotrexate) are discussed with an emphasis on distinguishing these entities from other categories of steatotic liver disease. In addition to pathology, the session highlights the importance of utilization of pathology reports to facilitate diagnosis and further work-up, and the utility and limitations of liver biopsy to narrow a differential diagnosis. Case presentations illustrate the importance of clinicopathologic correlation in different clinical settings.&nbsp;<br />
<br />
&nbsp;

MASLD, Obesity, Cardiometabolic Syndrome, T2DM are all overlapping yet distinct diseases. Follow a patient in real time from primary to tertiary care. Challenge the experts in hepatology, cardiology and obesity medicine as they debate the latest research and missed opportunities along the patient&rsquo;s journey: Juggle polypharmacy, lifestyle interventions, biomarkers, multimodal imaging. Interactive Evening Symposium. Dinner and Refreshments provided.<br />
<br />
For more information and to register, visit:&nbsp;<a href="https://healthpromatch.com/courseRegistration/?courseId=6">https://heal… />
<br />
Supported by:&nbsp;Perspectum Ltd<br />
<br />
Organized by: HealthProMatch<br />
<br />
Important Note: Continuing education credits for Satellite Symposia are offered by the sponsoring organizations. These sessions are not accredited by AASLD.